Article
RHAMM and CD44 peptides-analytic tools and potential drugs
26 Oct 2011
Abstract excerpt
CD44 and RHAMM are two extracellar matrix receptors whose principle ligand is the polysaccharide hyaluronan (HA). Both proteins are involved in wound repair and their aberrant regulation contributes to a variety of diseases including arthritis and cancer. Over the past decade, a number of peptide-based therapeutics that block the binding of CD44 or RHAMM-specific ligands have been developed and tested in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
